Mirum Pharmaceuticals, Inc. Common Stock MIRM
$93.18
-0.58%
at last close
Analyst Consensus
- Consensus Rating
- Buy (13 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $155.15
- Implied Upside
- +66.5%
- Price Target Range
- $125.00 – $202.00
- Analysts (12 mo)
- 13
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-11 | CitigroupYigal Nochomovitz |
Maintains | Buy | $184 → $194 |
| 2026-11-05 | Leerink PartnersMani Foroohar |
Maintains | Outperform | $154 → $140 |
| 2026-11-04 | RBC CapitalLisa Walter |
Reiterates | Outperform | $155 |
| 2026-11-04 | CitizensJonathan Wolleben |
Maintains | Market outperform | $144 → $167 |
| 2026-11-04 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $200 → $202 |
| 2026-11-04 | Cantor FitzgeraldJosh Schimmer |
Maintains | Overweight | $155 → $160 |
| 2026-10-21 | TD CowenJoseph Thome |
Maintains | Buy | $140 → $145 |
| 2026-10-15 | StifelJames Condulis |
Maintains | Buy | $136 → $156 |
| 2026-10-13 | Evercore ISI GroupGavin Clark-Gartner |
Maintains | Outperform | $135 → $146 |
| 2026-10-13 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $137 → $152 |
| 2026-10-12 | CitigroupYigal Nochomovitz |
Maintains | Buy | $160 → $184 |
| 2026-10-12 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $195 → $200 |
| 2026-10-08 | RBC CapitalLisa Walter |
Maintains | Outperform | $135 → $155 |
| 2026-09-29 | CitigroupYigal Nochomovitz |
Maintains | Buy | $145 → $160 |
| 2026-09-29 | BairdBrian Skorney |
Maintains | Outperform | $123 → $130 |
| 2026-09-28 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $140 → $195 |
| 2026-08-27 | CitizensJonathan Wolleben |
Reiterates | Market outperform | $137 |
| 2026-08-06 | TD CowenJoseph Thome |
Maintains | Buy | $145 → $140 |
| 2026-08-06 | RBC CapitalLisa Walter |
Maintains | Outperform | $148 → $135 |
| 2026-08-06 | CitizensJonathan Wolleben |
Maintains | Market outperform | $146 → $137 |
| 2026-08-06 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $185 → $140 |
| 2026-07-07 | RBC CapitalLisa Walter |
Maintains | Outperform | $142 → $148 |
| 2026-07-02 | JP MorganJessica Fye |
Maintains | Overweight | $115 → $125 |
| 2026-06-15 | CitizensJonathan Wolleben |
Maintains | Market outperform | $140 → $146 |
| 2026-06-11 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $140 → $150 |
| 2026-06-02 | CitigroupYigal Nochomovitz |
Initiates coverage on | Buy | $145 |
| 2026-05-19 | Wolfe ResearchKalpit Patel |
Initiates coverage on | Outperform | $145 |
| 2026-05-07 | TD CowenJoseph Thome |
Maintains | Buy | $125 → $145 |
| 2026-05-07 | RBC CapitalLisa Walter |
Maintains | Outperform | $128 → $142 |
| 2026-05-07 | Evercore ISI GroupGavin Clark-Gartner |
Maintains | Outperform | $135 → $138 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $93.18
- Market Cap
- $6.08 billion
- 52-Week Range
- $63.23 – $130.00
- Average Volume
- 754K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.